Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis
Author(s)
Johnson B1, T S2, Johnston S3, Gunja N4
1Johnson & Johnson, Lincoln, NH, USA, 2Mu Sigma, Bengaluru, Karnataka, India, 3Johnson & Johnson MedTech, New Brunswick, NJ, USA, 4J&J MedTech, Markham, ON, Canada
Presentation Documents
OBJECTIVES: To examine the trends and outcomes of knotless tissue control devices (KTCD) (Ethicon, Inc.) vs. smooth sutures for wound closure in robotic ventral hernia repair.
METHODS: Retrospective analysis of hospital data from the US Premier Healthcare Database. Study subjects were age ≥18 years and had a robotic surgical admission for ventral hernia repair (VHR) between 10/01/2015-06/30/2022 (first admission=index). Quarterly KTCD utilization trends were measured descriptively. Outcomes measured during the surgical admission included: operating room (OR) time, in-hospital through 90-day post-discharge wound-related complications, and total hospital costs. We used 1:1 propensity score matching to balance the KTCD and smooth suture groups on numerous patient and hospital/provider characteristics. Generalized estimating equations, accounting for hospital-level clustering, with link functions and error distributions tailored to the empirical distribution of post-match outcomes, were used to test for statistically significant differences between the KTCD and smooth sutures groups.
RESULTS: From Q4 2015 to Q2 2022, KTCD utilization more than doubled in robotic VHR (from 12.2% to 25.3%). Among 32,469 identified patients, after matching, 6,687 patients remained in each group (13,374 total); median age 57 years, 53.1% female. The observed OR time was lower in the KTCD group as compared with the smooth sutures group (154.3 minutes-KTCD vs. 172.7 minutes-smooth sutures, difference=18.4 minutes [95% CI -32.7 to -4.0], P=0.012). The observed incidence proportion of wound-related complications was similar between the groups (0.91%-KTCD vs. 0.91%- smooth sutures, difference=0.0% [95% CI -0.34% to 0.34%], P=1.000). Total hospital costs were also similar between the groups ($10,719-KTCD vs. $10,720- smooth sutures, difference=$1 [95% CI -$1,114 to $1,112], P=0.999).
CONCLUSIONS: In this retrospective study of patients undergoing robotic VHR, adoption of KTCD grew substantially over the past 6 years. While most clinical and economic outcomes were similar between the two groups, KTCD was associated with significantly lower operating room time vs. smooth sutures.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Code
MT40
Topic
Clinical Outcomes, Economic Evaluation, Medical Technologies, Study Approaches
Topic Subcategory
Comparative Effectiveness or Efficacy, Cost-comparison, Effectiveness, Utility, Benefit Analysis, Medical Devices
Disease
Medical Devices
Explore Related HEOR by Topic